Management of malignant pleural effusions

Alexandra Dipper; Rahul Bhatnagar; Nick Maskell

doi:10.1097/MCP.0000000000000685

Management of malignant pleural effusions

Alexandra Dipper, Rahul Bhatnagar, Nick Maskell^*

^*Corresponding author for this work

Research output: Contribution to journal › Article (Academic Journal) › peer-review

3 Citations (Scopus)

43 Downloads (Pure)

Abstract

PURPOSE OF REVIEW: Malignant pleural effusion (MPE) is a common cause of breathlessness indicative of advanced disease. Treatment approaches focus on relief of breathlessness and optimizing quality of life. A number of recent, high-impact publications give further insight into the advantages of different treatment options. This article provides a summary of the most up-to-date evidence in this area.

RECENT FINDINGS: Recent publications have demonstrated comparable pleurodesis outcomes of talc slurry to talc poudrage and explore strategies to combine the advantages of indwelling pleural catheters (IPCs) with a chemical pleurodesis. A daily IPC drainage regime improves the chances of pleurodesis success and early IPC removal in patients without significant trapped lung.

SUMMARY: MPE is a diverse condition, with no one strategy representing the 'best' approach for all. Management decisions should be made in conjunction with the patient, taking their views and preferences into consideration.

Original language	English
Pages (from-to)	341-345
Number of pages	5
Journal	Current Opinion in Pulmonary Medicine
Volume	26
Issue number	4
DOIs	https://doi.org/10.1097/MCP.0000000000000685
Publication status	Published - 1 Jul 2020

Keywords

malignant pleural effusion
pleurodesis
Indwelling Pleural Catheter
IPC

Access to Document

10.1097/MCP.0000000000000685

Full-text PDF (author’s accepted manuscript)
This is the final published version of the article (version of record). It first appeared online via Lippincott, Williams & Wilkins at https://journals.lww.com/co-pulmonarymedicine/Abstract/2020/07000/Management_of_malignant_pleural_effusions.5.aspx . Please refer to any applicable terms of use of the publisher.
Accepted author manuscript, 213 KB

Handle.net

Persistent link

Cite this

@article{61199373cf3743dab61f34913b67259c,

title = "Management of malignant pleural effusions",

abstract = "PURPOSE OF REVIEW: Malignant pleural effusion (MPE) is a common cause of breathlessness indicative of advanced disease. Treatment approaches focus on relief of breathlessness and optimizing quality of life. A number of recent, high-impact publications give further insight into the advantages of different treatment options. This article provides a summary of the most up-to-date evidence in this area.RECENT FINDINGS: Recent publications have demonstrated comparable pleurodesis outcomes of talc slurry to talc poudrage and explore strategies to combine the advantages of indwelling pleural catheters (IPCs) with a chemical pleurodesis. A daily IPC drainage regime improves the chances of pleurodesis success and early IPC removal in patients without significant trapped lung.SUMMARY: MPE is a diverse condition, with no one strategy representing the 'best' approach for all. Management decisions should be made in conjunction with the patient, taking their views and preferences into consideration.",

keywords = "malignant pleural effusion, pleurodesis, Indwelling Pleural Catheter, IPC",

author = "Alexandra Dipper and Rahul Bhatnagar and Nick Maskell",

year = "2020",

month = jul,

day = "1",

doi = "10.1097/MCP.0000000000000685",

language = "English",

volume = "26",

pages = "341--345",

journal = "Current Opinion in Pulmonary Medicine",

issn = "1070-5287",

publisher = "Lippincott Williams and Wilkins",

number = "4",

}

TY - JOUR

T1 - Management of malignant pleural effusions

AU - Dipper, Alexandra

AU - Bhatnagar, Rahul

AU - Maskell, Nick

PY - 2020/7/1

Y1 - 2020/7/1

N2 - PURPOSE OF REVIEW: Malignant pleural effusion (MPE) is a common cause of breathlessness indicative of advanced disease. Treatment approaches focus on relief of breathlessness and optimizing quality of life. A number of recent, high-impact publications give further insight into the advantages of different treatment options. This article provides a summary of the most up-to-date evidence in this area.RECENT FINDINGS: Recent publications have demonstrated comparable pleurodesis outcomes of talc slurry to talc poudrage and explore strategies to combine the advantages of indwelling pleural catheters (IPCs) with a chemical pleurodesis. A daily IPC drainage regime improves the chances of pleurodesis success and early IPC removal in patients without significant trapped lung.SUMMARY: MPE is a diverse condition, with no one strategy representing the 'best' approach for all. Management decisions should be made in conjunction with the patient, taking their views and preferences into consideration.

AB - PURPOSE OF REVIEW: Malignant pleural effusion (MPE) is a common cause of breathlessness indicative of advanced disease. Treatment approaches focus on relief of breathlessness and optimizing quality of life. A number of recent, high-impact publications give further insight into the advantages of different treatment options. This article provides a summary of the most up-to-date evidence in this area.RECENT FINDINGS: Recent publications have demonstrated comparable pleurodesis outcomes of talc slurry to talc poudrage and explore strategies to combine the advantages of indwelling pleural catheters (IPCs) with a chemical pleurodesis. A daily IPC drainage regime improves the chances of pleurodesis success and early IPC removal in patients without significant trapped lung.SUMMARY: MPE is a diverse condition, with no one strategy representing the 'best' approach for all. Management decisions should be made in conjunction with the patient, taking their views and preferences into consideration.

KW - malignant pleural effusion

KW - pleurodesis

KW - Indwelling Pleural Catheter

KW - IPC

U2 - 10.1097/MCP.0000000000000685

DO - 10.1097/MCP.0000000000000685

M3 - Article (Academic Journal)

C2 - 32487872

SN - 1070-5287

VL - 26

SP - 341

EP - 345

JO - Current Opinion in Pulmonary Medicine

JF - Current Opinion in Pulmonary Medicine

IS - 4

ER -

Management of malignant pleural effusions

Abstract

Keywords

Access to Document

Handle.net

Fingerprint

Cite this